Eduardo Bruera

Sep 11, 2024 | jamanetwork.com | Eduardo Bruera |Jennifer Temel |Vicki Jackson |Areej El-Jawahri

Improving Palliative Care Access for Patients With Cancer Stepped Palliative Care for Patients With Advanced Lung Cancer Jennifer S. Temel, MD; Vicki A. Jackson, MPH, MD; Areej El-Jawahri, MD; Simone P. Rinaldi, MSN, ANP-BC, ACHPN; Laura A. Petrillo, MD; Pallavi Kumar, MD; Kathryn A. McGrath, MD; Thomas W. LeBlanc, MD; Arif H. Kamal, MD; Christopher A. Jones, MD; Dustin J. Rabideau, PhD; Nora Horick, MS; Kedie Pintro, MS; Emily R. Gallagher Medeiros, RN; Kathryn E.

Jun 28, 2024 | mdanderson.org | Eduardo Bruera

Steroids are a natural part of your body produced by your adrenal glands. They’re hormones that help regulate your body’s reaction to infection or injury, the speed of your metabolism and more. In medicine, we use artificial steroids called corticosteroids when the body cannot make its own. This is known as steroid replacement. Sometimes, we use steroids as medicine delivered in higher doses.

Jun 5, 2024 | agsjournals.onlinelibrary.wiley.com | Columba Thomas |Eduardo Bruera |William Breitbart |Yesne Alici

The care of older persons at the end of life often involves competing concerns and highly value-sensitive decisions. In a recent article, we proposed a set of ethical rules—the canons of therapy—to help clinicians navigate complex cases involving older adults with delirium at the end of life.1 The canons of therapy most pertinent to such cases are restoration, means-end proportionality, discretion, and parsimony (see Table 1 for a description).

May 1, 2024 | spcare.bmj.com | Silvia Allende-Pérez |Oscar Rodríguez-Mayoral |Adriana Peña-Nieves |Eduardo Bruera

AbstractObjective Accurate forecasting the life expectancy of patients with cancer is adamantly needed for adequate decision-making in the Palliative Care Services (PCS) context. Nonetheless, physician forecast is often inaccurate, hindering end of life (EOL) decisions. In this study, we determined the prognostic value of two oncology performance status (PS) scales at first referral to PCS.

May 1, 2024 | spcare.bmj.com | Carlos Eduardo Paiva |David SC Hui |Eduardo Bruera |Miguel Julião

AbstractObjectives To evaluate the preferred place-of-death (PPoD) among patients with advanced cancer over time, and the concordance between preferred and actual place-of-death. Methods Prospective cohort study. A total of 190 patients with advanced cancer and their caregivers (n=190) were interviewed every 3 months, from study enrolment to 12 months (M0, M1, M2, M3, M4).